Publication: Prevalence of onychomycosis in patients with autoimmune diseases
Issued Date
2006-09-15
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-33748514352
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.89, No.8 (2006), 1249-1252
Suggested Citation
Papapit Tuchinda, Waranya Boonchai, Puangpetch Prukpaisarn, Chanai Maungprasat, Puan Suthipinittharm Prevalence of onychomycosis in patients with autoimmune diseases. Journal of the Medical Association of Thailand. Vol.89, No.8 (2006), 1249-1252. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/23608
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prevalence of onychomycosis in patients with autoimmune diseases
Other Contributor(s)
Abstract
Background: Onychomycosis is the most common nail disorder in adults. Many studies reported a higher prevalence of onychomycosis among particular patients, such as those with diabetes, poor peripheral circulation or immunosuppression. However, studies of the prevalence of onychomycosis in autoimmune patients who carry many of these predisposing factors have been limited. Objective: Study the prevalence of onychomycosis in autoimmune compared to non-autoimmune female patients Material and Method: A cross-sectional study of the prevalence of onychomycosis in autoimmune patients and non-autoimmune female patients visiting a dermatology clinic over a period of 18 months. One hundred and sixty-five female autoimmune patients were enrolled. Results: The prevalence of onychomycosis in autoimmune patients was 10.2% (95%CI 6.5%, 15.9%) compared to 6.7% (95%CI 3.8%, 11.6%), in non-autoimmune patients (p > 0.05, 2-sided). Of vesiculobullous patients, mainly presenting with pemphigus and who were mostly on immunosuppressive medication, 24% had onychomycosis [p = 0.013; OR 4.39 (95%CI 1.27, 14.89)]. Conclusion: Exposure to humid microenvironments was an important factor in the occurrence of onychomycosis (p < 0.05, 2-sided). However, the number of patients with each individual disease was too small to conclude a prevalence of onychomycosis in conjunction with these individual cutaneous autoimmune diseases.